Concord Drugs Ltd
Concord Drugs Ltd Share Price Today: Live Updates & Key Insights
Get insights on Concord Drugs Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Concord Drugs Ltd Share Price Chart
CONCORDDRUGS at 10 Jul 2026 05:43 PM Pharmaceuticals
70.80 -1.01(-1.41%)
Lowest Today 70.00
Highest Today 76.40
Today's Open 76.40
Prev. Close 71.81
52 Week High 92.52
52 Week Low 29.00
Concord Drugs Ltd Fundamentals
Traded Volume: 4,929
Market Cap(Cr): 93.28
Avg Traded Price 70.96
1 Year return 21.55%
Upper Circuit 76.4
Lower Circuit 70
P/E TTM 0.00
P/B Ratio 1.950
Traded Value(Cr) 3.49
EPS TTM NaN
Book value/Share 36.820
Dividend Yield 1Y 0.00%
Concord Drugs Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Concord Drugs Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Concord Drugs Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W 0.00%
1M 0.00%
3M 0.00%
1Y +21.55%
YTD 0.00%
Concord Drugs Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Concord Drugs Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday N/A
Day Before Yesterday N/A
1W Avg N/A
1M Avg N/A
3M Avg N/A
Concord Drugs Ltd Technical Details
Concord Drugs Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 70
Support 2 68
Support 3 65
Pivot Point : 73
Resistance 1 75
Resistance 2 78
Resistance 3 80
Concord Drugs Ltd Corporate Actions
Concord Drugs Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Concord Drugs Ltd’s capital allocation strategies.
All
Dividends
No Dividend has been declared by CONCORDDRUGS
Bonus
No Bonus has been declared by CONCORDDRUGS
Splits
No Split has been declared by CONCORDDRUGS
Others
Rights No Rights has been declared by CONCORDDRUGS
Concord Drugs Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Concord Drugs Ltd with leading peers in the pharmaceuticals & biotechnology sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Concord Drugs Ltd's relative performance and valuation against major competitors.
Stock Name Denis Chem Lab Ltd ₹76.22 (-7.31%) M. Cap (Cr) 1.06 1 Yr Return (%) -23.59% P/E (TTM) 12.58 PB Ratio 1.16
Stock Name Vaishali Pharma Ltd ₹7.56 (+5.00%) M. Cap (Cr) 0.99 1 Yr Return (%) -40.75% P/E (TTM) 25.31 PB Ratio 1.46
Stock Name Mercury Laboratories Ltd ₹809.00 (+0.87%) M. Cap (Cr) 0.97 1 Yr Return (%) -5.93% P/E (TTM) 20.08 PB Ratio 1.67
Stock Name Concord Drugs Ltd ₹70.80 (-1.41%) M. Cap (Cr) 0.93 1 Yr Return (%) +21.55% P/E (TTM) 88.42 PB Ratio 1.92
Stock Name Makers Laboratories Ltd ₹149.90 (-2.73%) M. Cap (Cr) 0.88 1 Yr Return (%) -3.88% P/E (TTM) 37.20 PB Ratio 1.20
Stock Name Zenith Drugs Ltd ₹49.10 (-1.21%) M. Cap (Cr) 0.84 1 Yr Return (%) -28.74% P/E (TTM) 21.36 PB Ratio 1.12
Stock Name Curis Lifesciences Ltd ₹100.70 (0.00%) M. Cap (Cr) 0.81 1 Yr Return (%) NaN% P/E (TTM) 11.77 PB Ratio 1.72
Concord Drugs Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Concord Drugs Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2026 -7.37 Mar 2025 3.16 Mar 2024 1.96 Mar 2023 2.24 Mar 2022 0.77
PARTICULARS Investing Activities Mar 2026 -1.13 Mar 2025 -2.32 Mar 2024 -1.21 Mar 2023 -2.27 Mar 2022 0.01
PARTICULARS Financing Activities Mar 2026 8.65 Mar 2025 -0.87 Mar 2024 -0.69 Mar 2023 0.05 Mar 2022 1.68
PARTICULARS Net Cash Flow Mar 2026 0.16 Mar 2025 -0.02 Mar 2024 0.06 Mar 2023 0.03 Mar 2022 2.47
Concord Drugs Ltd Shareholding Pattern
This shows the ownership breakdown of Concord Drugs Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter N/A%
Public N/A%
Other Institutions N/A%
FII N/A%
Mutual Funds N/A%
About Concord Drugs Ltd
Concord Drugs Limited, established in 1995, is amongst the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small Volume parenterals, Dry Syrup powder) ,Tissue Bio-Adhesive, tablets, capsules and ophthalmic preparations and Ready-to-fill Pellets. The principal activity of the Company is to manufacture licensed drugs based on the formulations approved. The Company has two manufacturing facilities license issued by The Government of Andhra Pradesh, Drugs Control Administration, and Hyderabad. State of the art technology having dedicated manufacturing facilities for Liquid Injections, Dry powder Injections and Ready-to-fill Pellets ensures the highest level of process integrity and product quality.The Company started with Finished Pharmaceutical Formulations and then diversified into Ready-to-fill Pellets, to provide customers with end-to-end solution to their various pharmaceutical product needs to commercial contract drug manufacturing. It is engaged in developing New products Viz MUPS (Multiple Unit Pellet System), Sustained Release, Modified Release pellets with Innovative Drug Delivery Technologies by utilizing best and latest processing machinery. It operates a state of the art, cGMP contract manufacturing Formulation-Fill-Finish facility, providing comprehensive pharmaceutical development and manufacturing services for drug products.
Chairman / Executive Director / M D / Promoter
S Nagi Reddy
Registered office Survey No 249 Brahmanapally V, Hayathnagar M, Ranga Reddy, Telangana, 501511
FAX :91-40-24036379
Background
Incorporation Year 1995
Face Value ₹10.00
Market Lot 1
FAQs on Concord Drugs Ltd
How to buy Concord Drugs Ltd shares?
To buy Concord Drugs Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the market cap of Concord Drugs Ltd?
The company has a market capitalization of ₹93.28.
What is the PE & PB ratio of Concord Drugs Ltd?
PE is N/A and PB is 1.950.
What is the Concord Drugs Ltd dividend for 2025–26?
For the 2025–26 financial year, Concord Drugs Ltd declared a final dividend of null% per share.